Visium Asset Management’s Salix Pharmaceuticals SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
Visium Asset Management's SLXP Position: Q1 2015 in Review
Visium Asset Management sold out of Salix Pharmaceuticals (SLXP) in Q1 2015, closing a stake of 3,076,092 shares — an estimated $354M sold.
Visium Asset Management first reported a position in SLXP in Q3 2013 and held it in 6 quarters. The position peaked at $360M in Q3 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.
- Visium Asset Management reported no remaining Salix Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
- Visium Asset Management sold 3,076,092 Salix Pharmaceuticals shares in Q1 2015, an estimated $354M.
- Visium Asset Management first reported a position in Salix Pharmaceuticals in Q3 2013 and held it in 6 quarters.
- Visium Asset Management's Salix Pharmaceuticals position peaked at $360M in Q3 2014.
- 298 funds tracked by Wall St. Rank held Salix Pharmaceuticals as of Q1 2015.
Based on Visium Asset Management's 13F filing for Q1 2015, filed 15 May 2015.